Form 4: cbdMD, Inc. CEO and CFO Thomas Ronan Kennedy Reports Transaction
SEC Form 4 Filing
Thomas Ronan Kennedy, CEO and CFO of cbdMD, Inc., reports a transaction involving preferred stock and common stock.
Summary
- Thomas Ronan Kennedy, the CEO and CFO of cbdMD, Inc., filed a Form 4.
- The report details a transaction on September 23, 2024, involving 8% Series A Cumulative Convertible Preferred Stock and common stock.
- Kennedy acquired 38,465 shares of Preferred Stock at $270.
- He also indirectly owns 40,765 shares of common stock through the CRED Trust, for which he is the trustee.
- These shares were acquired at a price of $0.5993.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard reporting of transactions by an insider.
Industry Context
Form 4 filings are standard practice for company insiders to report transactions in their company's securities, providing transparency to the market.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 09/23/2024 | Date of the reported transaction involving preferred and common stock |
| 09/25/2024 | Date of signature on the Form 4 filing |
Keywords
Form 4, Beneficial Ownership, SEC Filing, YCBD, cbdMD, Inc., Kennedy, Preferred Stock, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.